These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9209906)
41. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer]. Fournel P Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400 [TBL] [Abstract][Full Text] [Related]
42. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325 [TBL] [Abstract][Full Text] [Related]
43. [Current data concerning neoadjuvant chemotherapy]. Depierre A Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148 [No Abstract] [Full Text] [Related]
44. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. Lee JS; Komaki R; Fossella FV; Glisson BS; Hong WK; Cox JD Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):479-86. PubMed ID: 9806504 [TBL] [Abstract][Full Text] [Related]
45. [The recent progress in chemoradiotherapy of lung cancer]. Ogawara M; Kawahara M; Furuse K Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514 [TBL] [Abstract][Full Text] [Related]
46. Combined modality treatment for locally advanced non-small cell lung cancer--which control arm? Johnson DH Lung Cancer; 1994 Mar; 10 Suppl 1():S231-8. PubMed ID: 7522113 [TBL] [Abstract][Full Text] [Related]
47. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. Komaki R; Seiferheld W; Ettinger D; Lee JS; Movsas B; Sause W Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):548-57. PubMed ID: 12062596 [TBL] [Abstract][Full Text] [Related]
48. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M; J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956 [TBL] [Abstract][Full Text] [Related]
49. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group. Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652 [TBL] [Abstract][Full Text] [Related]
50. Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer. Ardizzoni A; Grossi F; Scolaro T; Giudici S; Foppiano F; Boni L; Tixi L; Cosso M; Mereu C; Ratto GB; Vitale V; Rosso R Br J Cancer; 1999 Sep; 81(2):310-5. PubMed ID: 10496358 [TBL] [Abstract][Full Text] [Related]
51. Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data. Hotta K; Kiura K Ann Oncol; 2006 Nov; 17(11):1724. PubMed ID: 16790521 [No Abstract] [Full Text] [Related]
52. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
53. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study. Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942 [TBL] [Abstract][Full Text] [Related]
54. Current strategies for radiation therapy in non-small cell lung cancer. Arriagada R Chest; 1997 Oct; 112(4 Suppl):209S-213S. PubMed ID: 9337291 [TBL] [Abstract][Full Text] [Related]
55. Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer. MacRae R; Choy H Curr Oncol Rep; 2003 Jul; 5(4):313-7. PubMed ID: 12781074 [TBL] [Abstract][Full Text] [Related]
56. Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC). Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S Lung Cancer; 2015 May; 88(2):160-6. PubMed ID: 25758556 [TBL] [Abstract][Full Text] [Related]
57. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis. Pignon JP; Stewart LA Cancer; 1996 Jun; 77(11):2413-4. PubMed ID: 8635115 [No Abstract] [Full Text] [Related]
58. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer. Le Péchoux C; Arriagada R; Le Chevalier T; Bretel JJ; Cosset BP; Ruffié P; Baldeyrou P; Grunenwald D Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):519-25. PubMed ID: 8655375 [TBL] [Abstract][Full Text] [Related]
59. [Stage III NSCLC. The role of the chemotherapist]. Westeel V Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S95-8. PubMed ID: 18971832 [TBL] [Abstract][Full Text] [Related]
60. Combination of radiotherapy and chemotherapy in locally advanced NSCLC. Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B Expert Rev Anticancer Ther; 2009 Oct; 9(10):1389-403. PubMed ID: 19827998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]